Bridge to Life™ Secures FDA De Novo Clearance for VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System, the First Device Cleared in the U.S. for Hypothermic Oxygenated ...

Bridge to Life™ Ltd., a global innovator in organ preservation and perfusion technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo clearance for the ...
Yahoo Finance

Perfusion Systems Market to Reach USD 1.9 Billion by 2032, Growing at 4.5% CAGR

LOS ANGELES, Oct. 20, 2023 (GLOBE NEWSWIRE) -- The Global Perfusion Systems Market Size accounted for USD 1.3 Billion in 2022 and is projected to achieve a market size of USD 1.9 Billion by 2032 ...